Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
2
40%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Early Phase 1First-in-human
2(100.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 12 (100.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completed

Improving Diagnostic Standards in Dysphagia

NCT04773184
completed

Community Acquired Pneumonia in Older Adults

NCT04709978
completed

Screening in Oculopharyngeal Muscular Dystrophy

NCT02877784
completedearly_phase_1

Respiratory Strength Training in Persons With Amyotrophic Lateral Sclerosis (ALS)

NCT02710110
completedearly_phase_1

Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)

NCT02710162

Clinical Trials (5)

Showing 5 of 5 trials
NCT04773184

Improving Diagnostic Standards in Dysphagia

Completed
NCT04709978

Community Acquired Pneumonia in Older Adults

Completed
NCT02877784

Screening in Oculopharyngeal Muscular Dystrophy

Completed
NCT02710110Early Phase 1

Respiratory Strength Training in Persons With Amyotrophic Lateral Sclerosis (ALS)

Completed
NCT02710162Early Phase 1

Accurate Screening Tools for Dysphagia in Amyotrophic Lateral Sclerosis (ALS)

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5